China Stock Soars (CPHI)

NEW YORK (TheStreet) -- Shares of China Pharma (AMEX:CPHI) have taken a tremendous swing upward. The stock is trading at 82 cents as of 3:59 p.m. ET, 23.3% above Tuesday's closing price of 66 cents. Volume is at 317,747, 4.4 times the daily average of 72,300.

China has a market cap of $29.6 million and is part of the health care sector and drugs industry. Shares are down 0.7% year to date as of the close of trading on Tuesday.

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical products primarily to hospitals and private retailers in the People's Republic of China. The company has a P/E ratio of 1.5, above the average drugs industry P/E ratio of 1.3 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates China as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, weak operating cash flow and a generally disappointing performance in the stock itself. You can view the full China Ratings Report.

See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.

Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting SOAR to 95370 or select from multiple alert options.

For more information on China Pharma Holding Inc. click any of the following:

• China Pharma Holding Inc. Stock Price

• China Pharma Holding Inc. Analyst Ratings

• China Pharma Holding Inc. Key Stats & Profile

• China Pharma Holding Inc. Earnings

• China Pharma Holding Inc. Ratio Comparison

• China Pharma Holding Inc. Growth Rates

• China Pharma Holding Inc. Balance Sheet

• China Pharma Holding Inc. Cash Flow

• China Pharma Holding Inc. Income Statement